Can ARNI prevent atrial fibrillation in heart failure with reduced ejection fraction? Real-world evidence meets the randomized benchmark

Abstract

This editorial refers to ‘Switching to angiotensin receptor– neprilysin inhibitor and reduced risk of new-onset atrial fibrillation in heart failure with reduced ejection fraction: a nationwide propensity score–matched study’